Financial Summary (All financials)
| In millions, except per share items | Dec-31-08 | Dec-31-07 | Dec-31-05 | Dec-31-04 | Dec-31-03 |
| Revenues | 1.9 | 1.1 | 0.5 | 1.0 | 0.4 |
| Revenue growth | 73.7% | | -46.2% | 146.6% | |
| Cost of goods sold | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.9 | 0.1 | 0.5 | 1.0 | 0.4 |
| Gross margin | 46.0% | 9.5% | 96.9% | 96.7% | 93.6% |
| Selling, general and administrative | 2.4 | 3.4 | 9.0 | 9.4 | 6.6 |
| Research and development | | | 2.1 | 5.2 | 6.1 |
| EBIT | -2.1 | -3.6 | -9.8 | -14.0 | -12.4 |
| EBIT margin | -112.4% | -331.8% | -1809.2% | -1387.9% | -3051.2% |
| Pre-tax income | -2.2 | -3.4 | -11.6 | -14.8 | -12.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -2.2 | -3.4 | -13.8 | -16.5 | -14.2 |
| Net margin | -114.8% | -318.0% | -2541.8% | -1635.9% | -3487.5% |
| |
| Diluted EPS | $216,200.00 | $31,616.47 | ($0.47) | ($2.23) | ($1.93) |
| Shares outstanding (diluted) | 0.0 | 0.0 | 29.5 | 7.4 | 7.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|